BLT's 1-billion-yuan powder production base is set to begin trial production in August, with an annual capacity reaching 3,000 to 4,000 tons. The FDA has for the first time approved in-hospital 3D-printed titanium alloy implants, signaling a shift toward decentralized medical powder markets. Meanwhile, China's MIIT, along with seven other ministries, has launched a national 'open competition' initiative to accelerate AM breakthroughs, as six new national additive manufacturing standards take effect on the same day. Domestic AM powders are now entering a phase of systematic competition at the kiloton scale.